Diabetes Research and Clinical Practice

Inhibition of tumor necrosis factor- with anti-diabetic agents
pp. 147-154(8)
Authors: Towns A.D.; Frayne J.; Hall L.; Barnard D.L.; Sidwell R.W.; Xiao W.; Player M.R.; Adah S.A.; Torrence P.F.; Fukuzawa M.; Satoh J.; Qiang X.; Miyaguchi S.; Sakata Y.; Nakazawa T.; Ikehata F.; Ohta S.; Toyota T.

Repaglinide versus glyburide: a one-year comparison trial
pp. 155-166(12)
Authors: Wang S.; Shen S.; Xu H.; Gu D.; Yin J.; Tang X.; Johnson R.A.; Huong S.-M.; Huang E.-S.; Marbury T.; Huang W.-C.; Strange P.; Lebovitz H.

Familial aggregation of diabetic kidney disease in Type 2 diabetes in south India
pp. 167-171(5)
Authors: Gabbutt C.D.; Hepworth J.D.; Heron B.M.; Jin Oon C.; Ning Chen W.; Lim N.; Koh S.; Keow Lim G.; Lin Leong A.; San Tan G.; Vijay V.; Snehalatha C.; Shina K.; Lalitha S.; Ramachandran A.

Pulmonary diffusing capacity, serum angiotensin-converting enzyme activity and the angiotensin-converting enzyme gene in Japanese non-insulin-dependent diabetes mellitus patients
pp. 173-177(5)
Authors: Griffiths J.; Cox R.; Burstein M.E.; Serbin A.V.; Khakhulina T.V.; Alymova I.V.; Stotskaya L.L.; Bogdan O.P.; Manukchina E.E.; Jdanov V.V.; Sharova N.K.; Bukrinskaya A.G.; Isotani H.; Nakamura Y.; Kameoka K.; Tanaka K.; Furukawa K.; Kitaoka H.; Ohsawa N.

Will acarbose improve the metabolic abnormalities of insulin-resistant type 2 diabetes mellitus?
pp. 179-185(7)
Authors: Freeman H.S.; Mason M.E.; Lye J.; Morrey J.D.; Bailey K.W.; Korba B.E.; Sidwell R.W.; Scott R.; Lintott C.J.; Zimmet P.; Campbell L.; Bowen K.; Welborn T.

An inverse correlation between serum leptin levels and hemoglobin A1c in patients with non-insulin dependent diabetes mellitus
pp. 187-191(5)
Authors: Shirai K.; Matsuoka M.; Fukunishi K.; Tebbe M.J.; Jensen C.B.; A. Spitzer W.; Franklin R.B.; George M.h.; Phillips D.L.; Moriya M.; Okumura T.; Takahashi N.; Yamagata K.; Motomura W.; Kohgo Y.

Long-term effect of epalrestat on cardiac autonomic neuropathy in subjects with non-insulin dependent diabetes mellitus
pp. 193-198(6)
Authors: Lye J.; Freeman H.S.; Mason M.E.; Singh P.; Lazarev V.N.; Shmarov M.M.; Zakhartchouk A.N.; Yurov G.K.; Misurina O.U.; Akopian T.A.; Grinenko N.F.; Grodnitskaya N.G.; Kaverin N.V.; Naroditsky B.S.; Ikeda T.; Iwata K.; Tanaka Y.

Haemochromatosis gene mutations Cys282Tyr and His63Asp are not increased in Type 2 diabetic patients compared with the Canterbury (New Zealand) general population
pp. 199-203(5)
Authors: Florkowski C.M.; George P.M.; Willis J.A.; Stott M.K.; Burt M.J.; Upton J.D.; Nesbit J.; Walmsley T.A.; Scott R.S.

Early presentation of type 2 diabetes mellitus in young New Zealand Maori
pp. 205-209(5)
Authors: Burkinshaw S.M.; Gotsopoulos A.; Efstathiou S.; Field H.J.; Griffiths P.D.; Kern E.R.; Sacks S.L.; Sawtell N.M.; Stanberry L.R.; McGrath N.M.; Parker G.N.; Dawson P.